News
AMT to be Acquired by uniQure
February 17, 2012 – The board of directors of Amsterdam Molecular Therapeutics (AMT) is recommending a substantial corporate restructuring and financing transaction which, if approved by shareholders, will result in the assets and certain liabilities being acquired by a newly formed private company, uniQure BV, and the AMT legal entity being liquidated and delisted.
NWO plans to invest over €225M in topsectors
February 16, 2012 - Also for the Topsector Life Sciences & Health (proposed investment €54M) the money would largely go to public-private partnerships. Herewith NWO contributes substantially to the means necessary to make the topsector policy a success.
New project organisation: amsterdam marketing
February 15, 2012 - Amsterdam’s new project organisation amsterdam marketing was launched on 1 February 2012.
Biogen Idec to Acquire Stromedix
February 14, 2012 - Biogen Idec and Stromedix have entered into a definitive agreement under which Biogen Idec will acquire Stromedix, a privately held biotechnology company focused on innovative therapies for fibrosis and organ failure.
Gunning president Executive Board UvA and HvA
February 10, 2012 - Prof. Louise Gunning-Schepers has been appointed president of the Executive Board of the University of Amsterdam (UvA) and the Hogeschool van Amsterdam, Amsterdam University of Applied Sciences (HvA) by the Supervisory Boards of the two institutions. The appointment is effective as of 1 April 2012.
Support Dutch representation at BIO
February 9, 2012 - In June, the Bio International Convention will take place in Boston MA. As it seems now, there will be no Dutch representation at the BIO, i.e., there will be no Holland Pavilion.
Medema president Netherlands Cancer Institute
February 3, 2012 - Prof. dr. Rene Medema is appointed as president of the board of directors of the Netherlands Cancer Institute.
VUmc, Bos Medical and Pontes develop innovative pillow for surgery
February 2, 2012 - During surgery, there is a chance that the patient develops pressure sores. To solve this, Pontes has initiated a cooperation between VUmc and Bos Medical to develop an innovative pillow system.
Knowledge agenda sets goals
January 31, 2012 - Minister of Health, Welfare and Sport Edith Schippers has sent the 'knowledge agenda' (kennisagenda) to parliament.
Biogen Idec Surpasses $5 Billion in 2011 Annual Revenue
January 31, 2012 - Biogen Idec, a global biotechnology leader in the discovery, development, manufacturing and commercialization of innovative therapies, today announced its full year and fourth quarter 2011 results.
Cortical Studios wins international film awards
January 31, 2012 - "Our Immune System" is an award-winning movie commissioned by Pfizer BV, that shows the complexity of inflammation and autoimmune diseases.
European Commission Delays Decision on Glybera Marketing Authorisation
January 30, 2012 – Amsterdam Molecular Therapeutics (AMT), a leader in the field of human gene therapy, was informed on Friday January 27, 2012 after business hours that the European Commission’s Standing Committee discussed on Monday January 22, 2012 the implementation decision not to grant marketing authorization for Glybera (alipogene tiparvovec) as recommended by the Committee for Human Medicinal Products (CHMP).
